2021
Press Releases
-
BRI President Jane Buckner, MD, Elected to FOCiS Leadership
-
New Researcher Dr. Oliver Harrison at the Benaroya Research Institute at Virginia Mason Receives $2.9 Million NIH R01 Grant to Study How the Immune System Responds to the Microbiome
-
New Study from the Benaroya Research Institute at Virginia Mason Finds "COVID-19 Immune Landscape Is Dynamically and Reversibly Correlated with Disease Severity"
-
Kay Branz to Retire From Benaroya Research Institute at Virginia Mason
2020
Press Releases
-
Thomas N. Wight, PhD, to Retire from Benaroya Research Institute at Virginia Mason
-
Early Introduction of Gluten May Prevent Celiac Disease in Children
-
Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses
-
GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
-
Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason
-
Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason
-
Benaroya Research Institute at Virginia Mason Announces More Than $5.8M in NIH Funding for COVID-19 Research
-
Dr. Oliver Harrison Awarded First NOSTER Science Microbiome Prize for Winning Essay on T Cells and Tissue Repair
-
Benaroya Research Institute Launches Gut Research Program
-
Hamid Bolouri, PhD, named Associate Member in the Center for Systems Immunology at Benaroya Research Institute at Virginia Mason
-
Benaroya Research Institute Welcomes Four New Board Members
BRI President Jane Buckner, MD, Elected to FOCiS Leadership
New Researcher Dr. Oliver Harrison at the Benaroya Research Institute at Virginia Mason Receives $2.9 Million NIH R01 Grant to Study How the Immune System Responds to the Microbiome
New Study from the Benaroya Research Institute at Virginia Mason Finds "COVID-19 Immune Landscape Is Dynamically and Reversibly Correlated with Disease Severity"
Kay Branz to Retire From Benaroya Research Institute at Virginia Mason
-
Thomas N. Wight, PhD, to Retire from Benaroya Research Institute at Virginia Mason
-
Early Introduction of Gluten May Prevent Celiac Disease in Children
-
Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses
-
GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
-
Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason
-
Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason
-
Benaroya Research Institute at Virginia Mason Announces More Than $5.8M in NIH Funding for COVID-19 Research
-
Dr. Oliver Harrison Awarded First NOSTER Science Microbiome Prize for Winning Essay on T Cells and Tissue Repair
-
Benaroya Research Institute Launches Gut Research Program
-
Hamid Bolouri, PhD, named Associate Member in the Center for Systems Immunology at Benaroya Research Institute at Virginia Mason
-
Benaroya Research Institute Welcomes Four New Board Members
